TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40

European Journal of Immunology

Volumn 41, Issue 7, 2011, Pages 2010-2020

  Hamano, Ryoko ^a,d   Huang, Jiaqiang ^b   Yoshimura, Teizo ^a   Oppenheim, Joost J ^a   Chen, Xin ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b A QIAGEN Company   (United States)

^c SAIC FREDERICK INC   (United States)

^d KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Co stimulation; Immune regulation; TNF; Tregs

Indexed keywords

CD134 ANTIGEN; CD137 ANTIGEN; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

4-1BB LIGAND; ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; FLOW CYTOMETRY; INFLAMMATION; INTERLEUKIN-2; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTORS;

EID: 79959722997     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041205     Document Type: Article

References (32)

1. Wing, K. and Sakaguchi, S., Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 2010. 11: 7-13.
2. + T regulatory cell-mediated suppression. Immunity 2009. 30: 636-645.
3. + T regulatory cells. J. Immunol. 2007. 179: 154-161.
4. + regulatory T cells in human peripheral blood. Eur. J. Immunol. 2010. 40: 1099-1106.
5. + T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J. Immunol. 2008. 180: 6467-6471.
6. Aggarwal, B. B. and Natarajan, K., Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 1996. 7: 93-124.
7. Kim, E. Y., Priatel, J. J., Teh, S. J. and Teh, H. S., TNF receptor type 2 (p75) functions as a costimulator for antigen-driven T cell responses in vivo. J. Immunol. 2006. 176: 1026-1035.
8. Kleijwegt, F. S., Laban, S., Duinkerken, G., Joosten, A. M., Zaldumbide, A., Nikolic, T. and Roep, B. O., Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells. J. Immunol. 2010. 185: 1412-1418.
9. Ablamunits, V., Bisikirska, B. and Herold, K. C., Acquisition of regulatory function by human CD8(+) T cells treated with anti-CD3 antibody requires TNF. Eur. J. Immunol. 2010. 40: 2891-2901.
10. Ma, H. L., Napierata, L., Stedman, N., Benoit, S., Collins, M., Nickerson-Nutter, C. and Young, D. A., Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells. Arthritis Rheum. 2010. 62: 430-440.
11. Mougiakakos, D., Johansson, C. C., Jitschin, R., Bottcher, M. and Kiessling, R., Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress. Blood 2011. 117: 857-861.
12. Grinberg-Bleyer, Y., Saadoun, D., Baeyens, A., Billiard, F., Goldstein, J. D., Gregoire, S., Martin, G. H. et al., Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J. Clin. Invest. 2010. 120: 4558-4568.
13. Annunziato, F., Cosmi, L., Liotta, F., Lazzeri, E., Manetti, R., Vanini, V., Romagnani, P. et al., Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J. Exp. Med. 2002. 196: 379-387.
14. + regulatory T cells inhibits the induction of inflammatory mediators. J. Immunol. 2008. 180: 2747-2751.
15. Nagar, M., Jacob-Hirsch, J., Vernitsky, H., Berkun, Y., Ben-Horin, S., Amariglio, N., Bank, I. et al., TNF activates a NF-kappaB-regulated cellular program in human CD45RA-regulatory T cells that modulates their suppressive function. J. Immunol. 2010. 184: 3570-3581.
16. Chen, X., Hamano, R., Subleski, J. J., Hurwitz, A. A., Howard, O. M. and Oppenheim, J. J., Expression of costimulatory TNFR2 induces resistance of CD4(+)FoxP3(-) conventional T cells to suppression by CD4(+)FoxP3(+) regulatory T Cells. J. Immunol. 2010. 185: 174-182.
17. van der Most, R. G., Currie, A. J., Mahendran, S., Prosser, A., Darabi, A., Robinson, B. W., Nowak, A. K. et al., Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy. Cancer Immunol. Immunother. 2009. 58: 1219-1228.
18. Minigo, G., Woodberry, T., Piera, K. A., Salwati, E., Tjitra, E., Kenangalem, E., Price, R. N. et al., Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog. 2009. 5: e1000402.
19. + T regulatory cells based on synergy between IL-2 and 4-1BB signaling. J. Immunol. 2007. 179: 7295-7304.
20. Ruby, C. E., Yates, M. A., Hirschhorn-Cymerman, D., Chlebeck, P., Wolchok, J. D., Houghton, A. N., Offner, H. et al., Cutting Edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right. J. Immunol. 2009. 183: 4853-4857.
21. Croft, M., The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 2009. 9: 271-285.
22. + regulatory T cell development. J. Immunol. 2008. 181: 3285-3290.
23. Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M. and Demengeot, J., Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 2003. 197: 403-411.
24. Fantuzzi, G., Di Santo, E., Sacco, S., Benigni, F. and Ghezzi, P., Role of the hypothalamus-pituitary-adrenal axis in the regulation of TNF production in mice. Effect of stress and inhibition of endogenous glucocorticoids. J. Immunol. 1995. 155: 3552-3555.
25. Birkeland, M. L., Copeland, N. G., Gilbert, D. J., Jenkins, N. A. and Barclay, A. N., Gene structure and chromosomal localization of the mouse homologue of rat OX40 protein. Eur. J. Immunol. 1995. 25: 926-930.
26. Piconese, S., Valzasina, B. and Colombo, M. P., OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection. J. Exp. Med. 2008. 205: 825-839.
27. Hirschhorn-Cymerman, D., Rizzuto, G. A., Merghoub, T., Cohen, A. D., Avogadri, F., Lesokhin, A. M., Weinberg, A. D.et al., OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis. J. Exp. Med. 2009. 206: 1103-1116.
28. Bhattacharya, P., Gopisetty, A., Ganesh, B. B., Sheng, J. R. and Prabhakar, B. S., GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms. J. Leukoc. Biol. 2011. 89: 235-249.
29. Griseri, T., Asquith, M., Thompson, C. and Powrie, F., OX40 is required for regulatory T cell-mediated control of colitis. J. Exp. Med. 2010. 207: 699-709.
30. Piconese, S., Pittoni, P., Burocchi, A., Gorzanelli, A., Care, A., Tripodo, C. and Colombo, M. P., A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2. Eur. J. Immunol. 2010. 40: 2902-2913.
31. Hippen, K. L., Harker-Murray, P., Porter, S. B., Merkel, S. C., Londer, A., Taylor, D. K., Bina, M. et al., Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood 2008. 112: 2847-2857.
32. + regulatory T cells. Curr. Dir. Autoimmun. 2010. 11: 119-134.